Scynexis (SCYX) Other Accumulated Expenses (2016 - 2026)
Scynexis' (SCYX) quarterly Other Accumulated Expenses came in at $809000.0 in Q1 2026, down 14.12% YoY from $942000.0 in Q1 2025, and up 69.25% on a QoQ basis from $478000.0 in Q4 2025.
Scynexis (SCYX) Other Accumulated Expenses (2016 - 2026) Analysis & Trends
Scynexis (SCYX) has 11 years of Other Accumulated Expenses data on file, last reported at $809000.0 in Q1 2026.
- Quarterly Other Accumulated Expenses fell 14.12% year-over-year to $809000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $809000.0 (down 14.12% YoY) and the FY2025 annual result came in at $478000.0, down 39.34% from the prior year.
- Other Accumulated Expenses rose to $809000.0 in Q1 2026, from $478000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $2.2 million in Q2 2022 to a low of $478000.0 in Q4 2025.
- A 5-year average of $1.1 million and a median of $895000.0 in 2025 frame the typical range for Other Accumulated Expenses.
- The widest YoY moves for Other Accumulated Expenses: up 79.6% in 2022, down 66.45% in 2022.
- Tracing SCYX's Other Accumulated Expenses over 5 years: stood at $1.3 million in 2022, then decreased by 20.79% to $1.0 million in 2023, then fell by 24.23% to $788000.0 in 2024, then sank by 39.34% to $478000.0 in 2025, then jumped by 69.25% to $809000.0 in 2026.
- The last three Other Accumulated Expenses figures came in at $809000.0 (Q1 2026), $478000.0 (Q4 2025), and $895000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Scynexis | 61.90 Mn | -52.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 669,000.00 |
| Mar 31, 2026 | 809,000.00 |
| Dec 31, 2025 | 478,000.00 |
| Sep 30, 2025 | 895,000.00 |
| Jun 30, 2025 | 757,000.00 |
| Mar 31, 2025 | 942,000.00 |
| Dec 31, 2024 | 788,000.00 |
| Sep 30, 2024 | 969,000.00 |
| Jun 30, 2024 | 862,000.00 |
| Mar 31, 2024 | 546,000.00 |
| Dec 31, 2023 | 1.04 Mn |
| Mar 31, 2023 | 1.54 Mn |
| Dec 31, 2022 | 1.31 Mn |
| Sep 30, 2022 | 720,000.00 |
| Jun 30, 2022 | 2.22 Mn |
| Mar 31, 2022 | 1.89 Mn |
| Dec 31, 2021 | 1.08 Mn |
| Sep 30, 2021 | 2.15 Mn |
| Jun 30, 2021 | 1.39 Mn |
| Mar 31, 2021 | 1.05 Mn |